Veracyte Names Tracy Morris as Vice President of Corporate Communications and Investor Relations
Veracyte, Inc. (VCYT)
Last veracyte, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.veracyte.com/investor-relations
Company Research
Source: Business Wire
Company also announces that Alfred “Freddie” Bowie, Jr., Ph.D. has been named to Savoy Magazine’s “2020 Most Influential Black Executives in Corporate America” List SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT) today announced that it has named Tracy Morris as vice president of corporate communications and investor relations, effective immediately. In this role, Ms. Morris will be responsible for the development and execution of Veracyte’s communications strategy to shareholders, customers, patients, employees and other audiences.Ms. Morris has over 25 years of experience in healthcare communications and public relations. She has served as a communications consultant to Veracyte for nearly ten years and to other leading molecular diagnostics and health technology companies and start-ups since 2003. For Veracyte, she provided communications leadership and support for the company’s market introduction, IPO, acquisition and collaboration announcements, pr
Show less
Read more
Impact Snapshot
Event Time:
VCYT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VCYT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VCYT alerts
High impacting Veracyte, Inc. news events
Weekly update
A roundup of the hottest topics
VCYT
News
- Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks? [Yahoo! Finance]Yahoo! Finance
- 3 Medical Instruments Industry Stocks to Buy on the GenAI Wave [Yahoo! Finance]Yahoo! Finance
- Those who invested in Veracyte (NASDAQ:VCYT) a year ago are up 68% [Yahoo! Finance]Yahoo! Finance
- Veracyte's Decipher Prostate Test Is Now the Only Gene Expression Test Recommended in NCCN® Prostate Cancer Guidelines [Yahoo! Finance]Yahoo! Finance
- Veracyte’s Decipher Prostate Test Is Now the Only Gene Expression Test Recommended in NCCN® Prostate Cancer GuidelinesBusiness Wire
VCYT
Earnings
- 11/6/24 - Beat
VCYT
Sec Filings
- 12/17/24 - Form 4
- 12/13/24 - Form 144
- 12/6/24 - Form 4
- VCYT's page on the SEC website